AFAR Expert in the News: Barzilai on gerotherapeutics, lifestyle, and extending healthspan in Oprah Daily
![AFAR Expert in the News: Barzilai on gerotherapeutics, lifestyle, and extending healthspan in Oprah Daily]()
On June 21, 2023, Oprah Daily featured insights from AFAR Scientific Director Nir Barzilai, MD, in the article, “A Guide on How to Live, Happier, Healthier, and Longer.”
Dr. Barzilai discusses how gerotherapeutics like metformin and rapamycin can impact the slowing of autophagy—the process through which a cell “clears out and recycles the junk”—as we age, helping prevent death from heart disease, cancer, cognitive decline, and Alzheimer’s. Dr. Barzilai also shares his insights on other methods to extend years of health, including exercise, nutrition, sleep, and social connectivity. “For me, the evidence is overwhelming,” says Dr. Barzilai. “People who check a lot of those boxes are in better health for longer.”
Read the article on Oprah Dailywith a subscription here.
A multiple AFAR grantee, Dr. Barzilai also directs the Institute for Aging Research at the Paul F. Glenn Center for the Biology of Human Aging Research, and the Nathan Shock Center of Excellence in the Basic Biology of Aging at Albert Einstein College of Medicine. At Einstein, he is also the Ingeborg and Ira Leon Rennert Chair of Aging Research, a professor in the Departments of Medicine and Genetics, and a member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics.